Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Paclitaxel trevatide shows activity in patients with breast cancer and CNS metastases

Dec. 24, 2015

SARM AUSRM-057 shows potential for colorectal cancer-associated cachexia

Dec. 24, 2015

Tamoxifen metabolite (Z)-endoxifen active against metastatic breast cancer in trial

Dec. 24, 2015

Intratumoral injection of EFEMP1-derived tumor suppression protein shows promise for brain cancer

Dec. 23, 2015

MEDI-3039: a potential therapeutic for TNBC

Dec. 23, 2015

Cell therapy improves functional and structural outcome after muscle trauma

Dec. 23, 2015

MAPKK inhibitor shows potential for the treatment of cancer cachexia

Dec. 23, 2015

Cerulean's tunable nanoparticle-drug conjugates are safe and effective antitumor agents

Dec. 23, 2015

Accurin nanoformulations improve antitumor activity and PK/PD profile

Dec. 23, 2015

OLIG2 pathway inhibitors show promise for the treatment of glioblastoma

Dec. 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...